KMT2A and acute myeloid leukemia: To evaluate whether these cell line observations were applicable in patient cells, we treated primary MLL-translocated AML cells from seven separate individuals (Table S5) for 7 days in stromal co-culture with vehicle, OG-86 250 nM, RAD001 2 μM or the combination.